ClinicalTrials.gg
Not yet recruitingNCT07924787Updated Nov 9, 2026

Clinician- vs. Patient-Reported Esthetic Outcomes After Coronally Advanced Flap

An interventional study of Coronally advanced flap with or without connective tissue graft in Connective Tissue Graft, Mucogingival Surgery and Gingival Recession, sponsored by Kutahya Health Sciences University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the relationship between clinician-assessed esthetic outcomes, measured using the Root Coverage Esthetic Score, and patient-reported esthetic outcomes, recorded on a Visual Analog Scale, at 6 months following the treatment of Cairo Recession Type 1 and Type 2 gingival recessions with a coronally advanced flap, combined with a connective tissue graft where clinically indicated.

Read the detailed description

In this prospective clinical study, patients who apply to our clinic due to the esthetic complaint or dentin sensitivity will be included. After initial periodontal treatment, patients who meet the criteria will have a coronally positioned flap applied under local anesthesia. In areas where the keratinized tissue width is 2 mm or more and the keratinized tissue thickness is more than 1 mm, a coronally positioned flap will be applied alone. In areas where the keratinized tissue width is less than 2 mm and/or the keratinized tissue thickness is 1 mm or less, a connective tissue graft will be applied in addition to the coronally positioned flap. Clinician and patient results will be compared in the esthetic evaluations to be performed six months after the surgical procedure.

02

Conditions studied

  • Connective Tissue Graft
  • Mucogingival Surgery
  • Gingival Recession
  • Esthetic

Browse trials for

03

In context

Gingival Recession

426 studies on the registry are indexed under Gingival Recession; 106 are open to participants now.

This study's planned enrollment of 40 is above the median of 30 across 390 interventional studies indexed under Gingival Recession.

Browse Gingival Recession studies →

Lead sponsor

Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Systemically healthy individuals
  • Individuals over 18 years of age
  • Individuals who do not smoke and/or consume alcohol
  • Individuals without active periodontitis
  • Individuals with full-mouth plaque and bleeding scores of less than 15%
  • Presence of single or multiple gingival recessions in the maxilla or mandible
  • The affected tooth must be single-rooted
  • Presence of Cairo classification Type 1 or Type 2 gingival recession on the buccal surface of the tooth
  • A recession depth of at least 2 mm

Exclusion criteria

Exclusion Criteria:

  • Individuals with uncontrolled systemic diseases
  • Women who are pregnant or breastfeeding
  • Individuals who smoke and/or consume alcohol
  • Individuals with active periodontitis
  • Cases involving tooth rotation or malposition
  • Individuals currently undergoing orthodontic treatment
  • Gingival recessions associated with teeth that have undergone endodontic treatment or require restorations
  • Teeth with dental caries
  • Gingival recessions with non-carious cervical lesions that have a horizontal depth (step depth) greater than 1 mm
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Coronally advanced flap procedure

    Coronally advanced flap procedure for Cairo type 1 or 2 gingival recession sites

    Procedure: Coronally advanced flap with or without connective tissue graft

Interventions

  • ProcedureCoronally advanced flap with or without connective tissue graft

    Patients will have a coronally positioned flap applied under local anesthesia. In areas where the keratinized tissue width is 2 mm or more and the keratinized tissue thickness is more than 1 mm, a coronally positioned flap will be applied alone. In areas where the keratinized tissue width is less than 2 mm and/or the keratinized tissue thickness is 1 mm or less, a connective tissue graft will be applied in addition to the coronally positioned flap.

06

What researchers measure

Primary outcomes

  1. Root Coverage Esthetic Score

    The Root Coverage Esthetic Score evaluates five variables 6 months following surgery (gingival margin, marginal tissue contour, soft tissue texture, mucogingival junction alignment, and gingival color).

    Time frame: Post-operative 6th month

  2. Patient-reported esthetic outcome

    Patient-reported esthetic outcome will be measured by the Visual Analog Scale (0 representing the minimum value, and 100 maximum value).

    Time frame: Post-operative 6th month

Secondary outcomes

  1. Recession depth

    The distance between gingival margin and cemento-enamel junction

    Time frame: Pre-operative and post-operative 6th month

  2. Keratinized tissue width

    The distance between gingival margin and mucogingival junction

    Time frame: Pre-operative and post-operative 6th month

  3. Keratinized tissue thickness

    The thickness measured 1.5 mm apical to the gingival margin

    Time frame: Pre-operative and post-operative 6th month

  4. Vestibular depth

    The distance between the gingival margin and the greatest concavity at the mucosal fold

    Time frame: Pre-operative and post-operative 6th month

  5. Mean root coverage

    (\[Pre-operative Recession Depth - Post-operative Recession Depth\] / Pre-operative Recession Depth) × 100

    Time frame: Post-operative 6th month

  6. Linear dimension change

    The changes in the horizontal plane measured by superimposition of the STL files

    Time frame: Post-operative 6th month

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

Of 233 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 12 months is below that.

Counting every sponsor, half of 235 studies reached it within 19 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartEst.
Nov 30, 2026
Primary completionEst.
Nov 30, 2027
CompletionEst.
Nov 30, 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07924787
Responsible party
Ezgi Gürbüz (Associate Professor, Kutahya Health Sciences University) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 30, 2026 (estimated)
Primary completion
Nov 30, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Ezgi Gürbüz, DDS PhD
Contact
ezgi.dogan@ksbu.edu.tr
+905557411860

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion